Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PI4Kβ inhibitors(phosphatidylinositol 4-kinase beta inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | SE | 30 Jan 2022 | |
Common Cold | Phase 1 | SE | 30 Jan 2022 | |
Influenza, Human | Phase 1 | SE | 30 Jan 2022 | |
Neoplasms | Phase 1 | SE | 30 Jan 2022 | |
Respiratory Syncytial Virus Infections | Phase 1 | SE | 30 Jan 2022 | |
Enterovirus Infections | Preclinical | SE | 22 Jul 2021 | |
Pulmonary Disease, Chronic Obstructive | Preclinical | SE | 22 Jul 2021 | |
Rhinovirus infection | Preclinical | SE | 22 Jul 2021 |